Gene · 5132
Papers1,377
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,377
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Paradoxical Expression of Ionotropic Glutamate Receptors in Leucocytes. | Clin Rev Allergy Immunol | 2026 | 41854785 | PubTator, text mining | PubMed |
| Glass ionomer open exposure and closed exposure of palatally displaced canines: a randomised controlled trail comparing postoperative pain perception and complications. | Eur J Orthod | 2026 | 41843643 | PubTator, text mining | PubMed |
| Diversity and evolution of archaeal immune strategies. | Nucleic Acids Res | 2026 | 41830331 | PubTator, text mining | PubMed |
| Stearic acid-modified PSMA-targeting peptide-drug conjugate for long-acting prostate cancer therapy. | Chem Sci | 2026 | 41816616 | PubTator, text mining | PubMed |
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
| Nanobiomaterial-enabled boron delivery systems and innovative strategies for revolutionizing BNCT. | Theranostics | 2026 | 41799206 | PubTator, text mining | PubMed |
| Solvent-Free Hydrogenation and Dehydrogenation of Quinoline and Quinaldine for the LOHC Concept. | ACS Omega | 2026 | 41799066 | PubTator, text mining | PubMed |
| Exploring metabolic signatures in urine using NMR for improved prognosis of gliomas. | Metabolomics | 2026 | 41790324 | PubTator, text mining | PubMed |
| Focusing on toxicity management: Challenges and strategies for HER2-targeted antibody-drug conjugates in breast cancer. | Breast | 2026 | 41785741 | PubTator, text mining | PubMed |
| BDCA2 plays a central role in the binding, internalization and response of plasmacytoid dendritic cells to vidutolimod. | Front Immunol | 2026 | 41777892 | PubTator, text mining | PubMed |
| Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma. | J Immunother Cancer | 2026 | 41775432 | PubTator, text mining | PubMed |
| Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma. | Research (Wash D C) | 2026 | 41756725 | PubTator, text mining | PubMed |
| Psychological Stress and Male Infertility: Oxidative Stress as the Common Downstream Pathway. | Biomedicines | 2026 | 41751158 | PubTator, text mining | PubMed |
| TTF2 as a potential biomarker and immunotherapy target in glioma diagnosis and prognosis. | Sci Rep | 2026 | 41748645 | PubTator, text mining | PubMed |
| Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer. | Curr Oncol | 2026 | 41744893 | PubTator, text mining | PubMed |
| Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions. | Bioact Mater | 2026 | 41737633 | PubTator, text mining | PubMed |
| 4,5-dihydroxyhexanoic acid is a robust circulating and urine marker of mitochondrial disease and its severity. | bioRxiv | 2026 | 41727150 | PubTator, text mining | PubMed |
| PDHA1 enhances resistance to ferroptosis in anoikis-resistant prostate cancer by upregulating AIFM2. | Cell Death Discov | 2026 | 41724793 | PubTator, text mining | PubMed |
| ADHD and adherence to antihypertensive medication treatment: a multinational cohort study. | BMC Med | 2026 | 41721349 | PubTator, text mining | PubMed |
| Targeted biologics for TNBC: Advances in nanobodies, antibodies, peptides, and aptamers. | Mol Ther Oncol | 2026 | 41716468 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5132/papers?page=3